Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-01
1991-03-26
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514269, 544319, 544328, A61K 31505, C07D23902
Patent
active
050029495
ABSTRACT:
A compound of the formula: ##STR1## in which R.sup.1 is --OH or --NH.sub.2 ; R.sup.2 is a halogen or --CN; R.sup.3 is a halogen or --CN; and n is one of the integers 1, 2 or 3; or a pharmaceutically acceptable salt thereof, are useful as antithrombotic agents.
REFERENCES:
patent: 3968214 (1976-07-01), Claverie et al.
patent: 4073905 (1978-02-01), Kummer et al.
patent: 4505910 (1985-03-01), Bagli
patent: 4617393 (1986-10-01), Bagli et al.
Derwent 14713S-B Abstract of JA-7106576-R.
Uchiyama et al., Stroke, 14 (4), 511 (1983).
Bagli Jehan F.
Colatsky Thomas J.
Heaslip Richard J.
Peseckis Steven M.
American Home Products Corporation
Jackson Richard K.
Kilby Scalzo Catherine S.
Waddell Frederick E.
LandOfFree
5-substituted-6-aminopyrimidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-substituted-6-aminopyrimidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-substituted-6-aminopyrimidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-617355